CALCIUM POLYSTYRENE SULFONATE: 138 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
138
Total FAERS Reports
29 (21.0%)
Deaths Reported
82
Hospitalizations
138
As Primary/Secondary Suspect
23
Life-Threatening
6
Disabilities
First Report: 20081212 · Latest Report: 20250402
What Are the Most Common CALCIUM POLYSTYRENE SULFONATE Side Effects?
#1 Most Reported
Hyperkalaemia
25 reports (18.1%)
#2 Most Reported
Acute kidney injury
15 reports (10.9%)
#3 Most Reported
Constipation
14 reports (10.1%)
All CALCIUM POLYSTYRENE SULFONATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperkalaemia | 25 | 18.1% | 3 | 16 |
| Acute kidney injury | 15 | 10.9% | 8 | 7 |
| Constipation | 14 | 10.1% | 5 | 6 |
| Crystal deposit intestine | 11 | 8.0% | 1 | 0 |
| Renal impairment | 10 | 7.3% | 1 | 8 |
| Large intestine perforation | 8 | 5.8% | 3 | 6 |
| Rash | 8 | 5.8% | 0 | 3 |
| Abdominal pain | 7 | 5.1% | 0 | 4 |
| Condition aggravated | 7 | 5.1% | 0 | 0 |
| Diarrhoea | 7 | 5.1% | 1 | 6 |
| Septic shock | 7 | 5.1% | 5 | 4 |
| Shock haemorrhagic | 7 | 5.1% | 2 | 6 |
| Pneumonia | 6 | 4.4% | 2 | 5 |
| Pruritus | 6 | 4.4% | 0 | 0 |
| Anaemia | 5 | 3.6% | 1 | 4 |
| Blood creatinine increased | 5 | 3.6% | 2 | 4 |
| Drug ineffective | 5 | 3.6% | 1 | 3 |
| Gastric disorder | 5 | 3.6% | 0 | 4 |
| Gastrointestinal necrosis | 5 | 3.6% | 1 | 5 |
| Hypokalaemia | 5 | 3.6% | 1 | 4 |
Who Reports CALCIUM POLYSTYRENE SULFONATE Side Effects? Age & Gender Data
Gender: 32.6% female, 67.4% male. Average age: 72.0 years. Most reports from: JP. View detailed demographics →
Is CALCIUM POLYSTYRENE SULFONATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 1 | 1 |
| 2010 | 2 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 1 | 2 |
| 2013 | 2 | 1 | 1 |
| 2014 | 6 | 3 | 5 |
| 2015 | 7 | 1 | 6 |
| 2016 | 13 | 2 | 8 |
| 2017 | 15 | 8 | 7 |
| 2018 | 6 | 0 | 4 |
| 2019 | 6 | 0 | 3 |
| 2020 | 2 | 1 | 1 |
| 2021 | 6 | 3 | 2 |
| 2022 | 8 | 0 | 7 |
| 2023 | 5 | 3 | 2 |
| 2024 | 4 | 0 | 3 |
| 2025 | 1 | 0 | 1 |
What Is CALCIUM POLYSTYRENE SULFONATE Used For?
| Indication | Reports |
|---|---|
| Hyperkalaemia | 73 |
| Product used for unknown indication | 32 |
| Chronic kidney disease | 9 |
CALCIUM POLYSTYRENE SULFONATE vs Alternatives: Which Is Safer?
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\CALCIUM
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\CHOLECALCIFEROL
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\CHOLECALCIFEROL\MAGNESIUM
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\DEXTROSE\HYDROCHLORIC ACID\MAGNESIUM\SODIUM BICARBONATE\SODIUM\SODIUM HYDROXIDE\SODIUM
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\DEXTROSE\MAGNESIUM\OXIGLUTATIONE\POTASSIUM\SODIUM BICARBONATE\SODIUM\SODIUM\SODIUM, DIBASIC
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\DEXTROSE\MAGNESIUM\SODIUM
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\DEXTROSE\MAGNESIUM\SODIUM BICARBONATE\SODIUM\SODIUM
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\ERGOCALCIFEROL
CALCIUM POLYSTYRENE SULFONATE vs CALCIUM\FAMOTIDINE\MAGNESIUM HYDROXIDE
Official FDA Label for CALCIUM POLYSTYRENE SULFONATE
Official prescribing information from the FDA-approved drug label.